CURE OM Steering Committee

The CURE OM Steering Committee is responsible for planning educational events and providing guidance and expertise for the CURE OM initiative. This collaborative international committee, composed of patients, caregivers, scientists, doctors, and MRF staff, is dedicated to improving the experience of people diagnosed with ocular melanoma. View the members of the CURE OM Scientific Steering Committee.

CURE OM Steering Committee 

Sara M. Selig, MD
Boston, Massachusetts
CURE OM Director, Melanoma Research Foundation
Department of Internal Medicine, Brigham and Women's Hospital

Sara's husband was diagnosed with a primary ocular melanoma in 2006 at the age of 34 and with metastatic disease in 2007. He lost his battle to the disease in 2012. Dr. Selig also sits on the CURE OM Scientific Steering Committee.

Molly Stoffa, RN
DeKalb, Illinois

Molly's mother-in-law was diagnosed with ocular melanoma in 2008. In 2011, her mother-in-law lost her battle to the disease after it became metastatic.

Robert Cheek
London, United Kingdom

Robert’s spouse was diagnosed with ocular melanoma in 2010.

Esther Damaser, PhD
Yellow Springs, Ohio

Esther was diagnosed with ocular melanoma in 1980, and since then has been a passionate advocate for improving access to research and treatment for patients with ocular melanoma. Read Esther’s story.

Anne Marie Montijo, MSW
New York

Mark Weinzierl
Frisco, Texas

Mark is an ocular melanoma survivor. He was treated for a primary tumor in July 2007. He continues to have regular follow-ups, and, to date, there is no evidence of spread of the disease.